From the Editor - BioPharm International


From the Editor

Hype vs. Health

November 1, 2014

Ebola Virus Disease (EVD) is a severe, often fatal disease that is transmitted human-to-human through bodily fluids.

A Silver Milestone for Drug Development

August 1, 2014

Pharmaceutical Technology Europe marks 25 years of drug-development advances.

Benefits and Risks of Drug Information on Social Media

July 1, 2014

FDA draft guidances seek to maintain accurate drug information in new media.

Biopharma Takes a Nervous Glance Over Its Shoulder

May 1, 2014

Changes are needed to maintain US biopharma innovation leadership.

Publishing Beyond the Printed Page

April 1, 2014

More media options open publishing opportunities for bioprocessing experts and authors.

Defining Quality Metrics is No Easy Task

February 1, 2014

ISPE and PDA take on the challenge of recommending quality metrics.

Drugs At What Cost?

January 1, 2014

Generics, market dynamics, and global demand are changing drug spending patterns.

Jobs Are Better in Biopharma, But There Is Room for Improvement

December 1, 2013

Higher wages and employment rates give biopharm professionals an edge over counterparts in other industries.

New Funding and Approval Pathways Prove Popular

November 1, 2013

The JOBS Act and FDASIA show early signs of accelerating drug development.



Click here